| Similar Articles |
|---|
 |
Salon.com
August 17, 2000
Stephen Lemons |
The great GHB-rape scare In Santa Barbara, the bizarre case of a Max Factor heir accused of sexual assault has refocused attention on the dangers of the drug that makes rape easy.   |
American Family Physician
June 1, 2004 |
Club Drugs-Myths and Risks This article provides a general overview on the topic of club drugs like Ecstasy. |
American Family Physician
June 1, 2004
Gahlinger |
Club Drugs: MDMA, Gamma-Hydroxybutyrate (GHB), Rohypnol, and Ketamine About club drugs, outcomes of ingestion and treatments after ingestion. |
American Family Physician
April 1, 2003 |
Substance Abuse--How To Recognize It Am I drinking too much?... Am I taking risks with alcohol or other mood-altering substances?... Has my drinking or drug use become a habit?... Is alcohol or drug use taking over my life?... Has drinking alcohol or using drugs become a problem for me?... etc. |
Chemistry World
November 14, 2006
Arthur Rogers |
New World of Cosmetovigilance Authorities on both sides of the Atlantic have taken steps to identify health risks from chemicals in cosmetics. |
Chemistry World
June 26, 2013
Andria Nicodemou |
Date rape drug sensor The first fluorescent sensor for known date rape drug gamma-butyrolactone has been developed in Singapore. It emits orange fluorescence in alcoholic drinks containing GBL when irradiated with a green laser. |
Chemistry World
October 25, 2007
Arthur Rogers |
European Ethical Guidelines Weigh in Against Mail Order Genetic Tests The Council of Europe (CoE) has come out against mail-order and over-the-counter genetic tests in new ethical guidelines that seek to address dilemmas faced by health services without hobbling scientific progress towards 'personalized medicine'. |
Chemistry World
February 7, 2006
Arthur Rogers |
Europe Gets Hot and Bothered Over Sun Cream Labelling Europe's cosmetics industry is launching a counter-offensive against demands for tougher regulation of the lucrative market in sun protection products. |
The Motley Fool
November 30, 2010
Brian Orelli |
A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist. |
